Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010

Heart

Volumn 101, Issue 16, 2015, Pages 1302-1308

  Tiwari, Sweta ^a   Schirmer, Henrik ^a,b   Jacobsen, Bjarne K ^a   Hopstock, Laila A ^a   Nyrnes, Audhild ^a   Heggelund, Geir ^a   Njølstad, Inger ^a   Mathiesen, Ellisiv B ^a,b   Løchen, Maja Lisa ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATRIAL FIBRILLATION; BODY HEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; COFFEE; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART HYPERTROPHY; HEART PALPITATION; HEART RATE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; TREND STUDY; VALVULAR HEART DISEASE; ATTITUDE TO HEALTH; COHORT ANALYSIS; COMPLICATION; DOPPLER ECHOCARDIOGRAPHY; HEART ATRIUM; HEART FAILURE, DIASTOLIC; INCIDENCE; MIDDLE AGED; MITRAL VALVE; MOTOR ACTIVITY; NORWAY; ORGAN SIZE; OUTCOME ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR;

ATRIAL FIBRILLATION; ATTITUDE TO HEALTH; CHOLESTEROL, HDL; COHORT STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART ATRIA; HEART FAILURE, DIASTOLIC; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MITRAL VALVE; MOTOR ACTIVITY; NORWAY; ORGAN SIZE; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84941639975     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-307438     Document Type: Article

References (30)

1. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52.
2. Magnani JW, Rienstra M, Lin H, et al. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation 2011;124:1982-93.
3. Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation:20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-64.
4. Gersh BJ, Tsang TSM, Barnes ME, et al. The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors. Eur Heart J Suppl 2005;7(Suppl C):C5-11.
5. Ahmad Y, Lip GY, Lane DA. Recent developments in understanding epidemiology and risk determinants of atrial fibrillation as a cause of stroke. Can J Cardiol 2013;29(7 Suppl):S4-13.
6. Vaziri SM, Larson MG, Benjamin EJ, et al. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994;89:724-30.
7. Qureshi W, Soliman EZ, Solomon SD, et al. Risk factors for atrial fibrillation in patients with normal versus dilated left atrium (from the Atherosclerosis Risk in Communities Study). Am J Cardiol 2014;114:1368-72.
8. Tsang TS, Gersh BJ, Appleton CP, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002;40:1636-44.
9. Vasan RS, Larson MG, Levy D, et al. Doppler transmitral flow indexes and risk of atrial fibrillation (the Framingham Heart Study). Am J Cardiol 2003;91:1079-83.
10. Jons C, Joergensen RM, Hassager C, et al. Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events in patients with acute myocardial infarction and depressed left ventricular systolic function: a CARISMA substudy. European J Echocardiogr 2010;11:602-7.
11. Jacobsen BK, Eggen AE, Mathiesen EB, et al. Cohort profile: the Tromso Study. Int J Epidemiol 2012;41:961-7.
12. Lindekleiv H, Løchen ML, Mathiesen EB, et al. Echocardiographic screening of the general population and long-term survival: a randomized clinical study. JAMA Intern Med 2013;173:1592-8.
13. Schirmer H, Lunde P, Rasmussen K. Mitral flow derived Doppler indices of left ventricular diastolic function in a general population; the Tromso study. Eur Heart J 2000;21:1376-86.
14. Arntzen KA, Schirmer H, Wilsgaard T, et al. Moderate wine consumption is associated with better cognitive test results: a 7 year follow up of 5033 subjects in the Tromso Study. Acta Neurol Scand Suppl 2010;122:23-9.
15. O'Rourke RA, Hanrath P, Henry WN, et al. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Recommendations for Standardization of Measurements from M-mode Echocardiograms. Circulation 1984;69:854A-7A.
16. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-93.
17. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.
18. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
19. Nyrnes A, Mathiesen EB, Njølstad I, et al. Palpitations are predictive of future atrial fibrillation. An 11-year follow-up of 22, 815 men and women: the Tromso Study. Eur J Prev Cardiol 2013;20:729-36.
20. Bangalore S, Yao SS, Chaudhry FA. Role of left atrial size in risk stratification and prognosis of patients undergoing stress echocardiography. J Am Coll Cardiol 2007;50:1254-62.
21. Tsang TS, Barnes ME, Gersh BJ, et al. Risks for atrial fibrillation and congestive heart failure in patients >/=65 years of age with abnormal left ventricular diastolic relaxation. Am J Cardiol 2004;93:54-8.
22. Patton KK, Ellinor PT, Heckbert SR, et al. N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation 2009;120:1768-74.
23. Rosenberg MA, Gottdiener JS, Heckbert SR, et al. Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J 2012;33:904-12.
24. Fatema K, Barnes ME, Bailey KR, et al. Minimum vs. maximum left atrial volume for prediction of first atrial fibrillation or flutter in an elderly cohort: a prospective study. Eur J Echocardiogr 2009;10:282-6.
25. Thomas L, Levett K, Boyd A, et al. Compensatory changes in atrial volumes with normal aging: is atrial enlargement inevitable? J Am Coll Cardiol 2002;40:1630-5.
26. Armstrong AC, Liu K, Lewis CE, et al. Left atrial dimension and traditional cardiovascular risk factors predict 20-year clinical cardiovascular events in young healthy adults: the CARDIA study. Eur Heart J Cardiovasc Imaging 2014;15:893-9.
27. Mottram PM, Marwick TH. Assessment of diastolic function: what the general cardiologist needs to know. Heart 2005;91:681-95.
28. Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002;90:1284-9.
29. Douglas PS. The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk. J Am Coll Cardiol 2003;42:1206-7.
30. Pritchett AM, Mahoney DW, Jacobsen SJ, et al. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 2005;45:87-92.